Related Experiment Video
Updated: May 10, 2025

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Hypophosphatasia: Clinical Clues and Management Considerations
Jason M Corless1,2, Alan J Bartholomew3, Joseph K Kluesner4
1Internal Medicine, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, USA.
Abstract:
This case report identifies typical manifestations of a patient with hypophosphatasia, a rare genetic condition in which mutations in tissue-non-specific alkaline phosphatase (TNSALP) enzymes cause low levels of alkaline phosphatase and defective bone mineralization. It explores common diagnostic clues from the history and laboratory evaluation, which can help clinicians identify the disorder. This case introduces a 49-year-old patient with a long history of fractures and dental abnormalities who was referred to endocrinology for evaluation of osteopenia. Further review of her laboratory data was noteworthy for a low level of alkaline phosphatase. Additionally, a low vitamin B6 level was measured, and genetic testing was ultimately diagnostic for hypophosphatasia. The patient was started on the anabolic agent teriparatide but was lost to subsequent follow-up. This case discusses additional management considerations, which are currently limited but continue to evolve, and cautions against bisphosphonate use in the setting of hypophosphatasia.
More Related Videos
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Acute Pancreatitis II: Clinical Manifestations and Management
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

